Day after British drug regulator approved AstraZeneca’s COVID-19 vaccine for emergency public use India’s drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter told Reuters.
A representative of India’s Central Drugs Standard Control Organization (CDSCO), whose experts were meeting for the second time this week, declined to comment.
India is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany’s BioNTech, and by India’s Bharat Biotech.
India has reported the second highest number of Coronavirus cases after the United States, though its rate of infection has come down significantly from a mid-September peak. India has reported more than 1 crore COVID-19 cases till now.